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Abstract Head and neck squamous cell carcinoma
(HNSCC) is the sixth most common non-skin cancer in the
world. Tobacco chewing is implicated with most of the
cases of HNSCC but this type of cancer is increasing in
non-tobacco chewers as well. This study was instigated to
provide comprehensive variant and gene-level data in
HNSCC subjects of the Indian population and fill the gap in
the literature on comparative assessment of gene mutations
in cancer subjects with a habit of tobacco and those without
any habit using targeted amplicon sequencing. We per-
formed targeted Amplicon sequencing of 409 tumor sup-
pressor genes and oncogenes, frequently mutated across
many cancer types, including head and neck. DNA from
primary tumor tissues and matched blood was analyzed for
HNSCC patients with a habit of tobacco and those without
any habit. PDE4DIP, SYNE1, and NOTCH1 emerged as
the highly mutated genes in HNSCC. A total of 39 candi-
date causal variants in 22 unique cancer driver genes were
identified in non-habitual (WoH) and habitual (WH) sub-
jects. Comparison of genes from both the subjects, showed
seven unique cancer driver genes (KIT, ATM, RNF213,
GATA2, DST, RET, CYP2C19) in WoH, while WH
showed five (IL7R, PKHD1, MLL3, PTPRD, MAPK8) and
10 genes (SETD2, ATR, CDKN2A, NCOA4, TP53,
SYNE1, KAT6B, THBS1, PTPRT, and FGFR3) were
common to both subjects. In addition to this NOTCH1,
NOTCH2, and NOTCH4 gene were found to be mutated
only in habitual subjects. These findings strongly support a
causal role for tobacco, acting via PI3K and MAPK path-
way inhibition and stimulation of various genes leading to
oncogenic transformations in case of tobacco chewers. In
case of non-tobacco chewers it appears that mutations in
the pathway affecting the squamous epithelial lineage and
DNA repair genes lead to HNSCC. Somatic mutation in
CYP2C19 gene in the non-habitual subjects suggests that
this gene may have a tobacco independent role in devel-
opment and progression of HNSCC. In addition to sharing
high mutation rate, NOTCH gene family was found to be
mutated only in habitual sample. Further, presence of
mutated genes not earlier reported to be involved in
HNSCC, suggest that the Indian sub-continent may have
different sets of genes, as compared to other parts of the
world, involved in the development and progression of
HNSCC.
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Introduction
Head and neck squamous cell carcinoma (HNSCC) is the
sixth most common non-skin cancer in the world. More
than 600,000 cases are reported per year having a mortality
rate of approximately 50 % (Bauman et al. 2012; Ferlay
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et al. 2010). India contributes to the highest number of
incident cases of oral cancer which approximates to
20–30 % of all cancers (http://wwwicmr.nic.in/cancer.pdf).
Tobacco chewing, smoking, ill-fitting dentures, poor oral
hygiene, syphilis, inadequate diet (lacking in fruits and
leafy vegetables), malnutrition, and chronic irritation from
rough or broken teeth are common causes implicated to
development of oral cancer. Recently, HNSCC has also
been associated with HPV virus (Lechner et al. 2013). Vast
majority of HNSCC originate due to tobacco chewing,
smoking, and/or alcohol consumption (Zeka et al. 2003).
However, there are incidences where people who never
chewed tobacco or consumed alcohol have developed oral
cancer (Subramanian and Govindan 2007). This indicates
involvement of genetic susceptibility as well as a complex
interaction of genetic and environmental factors in the
etiology of oral cancer (Imyanitov et al. 2004).
In the year 2011, the first ever reports of whole exome
sequencing of oral cancer patients were revealed (Agrawal
et al. 2011; Stransky et al. 2011). Agarwal et al. (2011)
sequenced *18,000 protein coding genes in tumors from
32 patients. A total of 911 candidate somatic mutations
were identified in 725 genes of 32 tumors. Stransky et al.
(2011) identified 130 coding mutations per tumor. The
common finding of both the groups included genes such as
TP53, CDKN2A, PIK3CA, and NOTCH1 to be the key
players in development of HNSCC. TP53 is the most
commonly mutated gene in HNSCC (Agrawal et al. 2011;
Stransky et al. 2011; Poeta et al. 2007). All these studies
majorly focus on HNSCC patients with a habit of tobacco
chewing but the 15 % patients without above-mentioned
habits and still found to have development of HNSCC
(Rodriguez et al. 2004) remain neglected. Till date there
are no reports available on the genetic analysis of these
types of patients. Hence, the aim of present study was to
analyze genes involved in progression and development of
HNSCC among tobacco habituated and non-habituated
HNSCC subjects and to analyze differences in the muta-
tional pattern among the two groups using Comprehensive
Ampliseq cancer panel of Life Technologies on Ion Torrent
Platform followed by bioinformatics analysis.
Materials and methods
Materials
DNA was derived from tumors and their matched normal
peripheral blood derived mononuclear cells (PBMNC) of
four patients. The study comprised three samples of four
HNSCC patients using both tumor tissues and matched
blood. Sample 1 consisted of tumor tissues of one patient
without any habit (WoH); sample 2 consisted of tumor
tissue of three patients with tobacco chewing habit (WH).
Matched blood of both WH and WoH was taken as control.
Tumor samples from the patients and the matched
peripheral blood samples were obtained from the Gujarat
Cancer and Research Institute. The demographics and the
clinical characteristics of the patient population including
age, gender, smoking habit use/exposures were taken as
shown in Table 1. Written informed consent was taken
from each subject as per institutional guidelines under
BioBank Project.
DNA extraction and sequencing
DNA was isolated from tumor tissue and control blood
sample using PureLink Genomic DNA Extraction Kit
(Invitrogen, USA). Qubit 2.0 Fluorometer (Invitrogen,
USA) was used to obtain an accurate quantitation of DNA.
DNA quality such as ratio of absorbance at 260/280 and
260/230 nm was measured using Nanophotometer (Imlpen,
USA). Library was prepared using Ion Express Plus Frag-
ment library kit (Life technologies, USA). DNA was
sheared into blunt-ended fragments by enzymatic lysis using
Ion Shear Plus Reagents. The fragments are ligated to Ion
XpressTM Barcode Adapters 1–16, followed by nick-repair
to complete the linkage between adapters and DNA inserts.
Amplicons were constructed using Ion AmpliSeqTM Com-
prehensive Cancer Panel (Life technologies, USA) targeting
409 tumor suppressor genes and oncogenes frequently cited
and frequently mutated (https://tools.lifetechnologies.com/
content/sfs/brochures/CO25560_Ion_AmpliSeq_Compreh
ensive_Cancer_Panel_Gene_List_final9062012.pdf). All
three barcoded libraries were mixed together in one equi-
molar sample and subsequently processed according to the
manufacturer’s protocol using the Ion Xpress Barcode
Adaptor kit and sequenced in the Ion TorrentTM Personal
Genome MachineTM (PGMTM) using an Ion 318TM chip and
the Ion Sequencing Kit (300 bp chemistry).
Data analysis
Reads were mapped onto human hg19 reference genome
and quality was assessed by filtering polyclonal and noisy
reads, clipping adapters, and low quality reads in Torrent
Suite Software 3.4.1 on Ion PGM Torrent Server (http://
products.invitrogen.com/ivgn/product/4477685). Barcoded
samples were separated and SNVs, insertions and deletions
were called using the recommended Torrent Variant Caller
3.6 Plug-in (http://mendel.iontorrent.com/ion-docs/
Torrent?Variant?Caller?Plugin.html) with default preset
parameters, optimized for ion AmpliSeq comprehensive
cancer panel.
Ion Reporter software was used for automated variant
annotation derived from public databases (dbSNP,
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COSMIC, Ensemble, RefSeq) (https://ionreporter.
lifetechnologies.com/ir/), which produce classified and
annotated variants calls. Ingenuity Variant Analysis soft-
ware, integerated in the Ion reporter software was used for
identification of causal variants and its association with the
disease. Low quality variants were filtered out with base
call quality\20, to keep only high quality variants. Vari-
ants in each sample were compared using online VENNY
tool (http://bioinfogp.cnb.csic.es/tools/venny/) to classify
into germline and somatic variants.
Non-coding, intronic, and UTR variants were filtered out to
keep only coding and splice site variants. Annotated variants
found in dbSNP (Sherry et al. 2001) were identified as known
variants and variants found in COSMIC database (Bamford
et al. 2004)were identifiedas cancer associated variants.Novel
variants were subjected to Polyphen2 (http://genetics.bwh.
harvard.edu/pph2/) and SIFT (http://sift.jcvi.org/) software,
integrated in ingenuity variant analysis tool for prediction of
possible damaging functional effects of variants.
Results
To accomplish the purpose of the study, three samples from
four HNSCC subjects were taken. Sample 1 consisted of
tumor tissues of cancer subject without any habit (hereafter
referred to as WoH), sample 2 that of subjects with
smoking and tobacco chewing habit (hereafter referred to
as WH), and sample 3 matched normal lymphocytes of
sample 1 and 2 which served as control. All three samples
were subjected to targeted amplicon sequencing using
Ampliseq Comprehensive cancer panel of Life Technolo-
gies on the Ion Torrent Platform.
Reference mapping of reads with human genome (hg19)
resulted into 88.6 MB data of 9,61,743 reads for WoH,
119 MB data constituting 12,92,207 reads for WH, and
143 MB of 15,42,354 reads for control as shown in
Table 2. An average read length of 110 bp and longest read
length of 379 bp was obtained. It was possible to map more
than 97 % of reads to target regions with reference gen-
ome. High quality reads at 209 coverage were 88 % for
WoH, 86 % for WH, and 93 % for control. Mean reads
depth coverage was found to be 59.4-fold for WoH, 79.6-
folds for WH, and 95.5-fold for control, meeting the
requirement of obtaining 100 % variant calling sensitivity.
Variant analysis
Further, WoH and WH detected 934 and 959 variations like
SNPs, insertions and deletions in 280 and 275 genes,
respectively, whereas 1,354 variants in 318 genes detected in
control (Table 3). Ti/Tv ratio and dbSNP rate of variants was
calculated for statistically validating variant calling quality in
each sample. Ratio was calculated for the number of transi-
tions to the number of transversions as it is particularly
helpful for assessing the quality of SNP calls (Kalavrezos
et al. 2012). Ti/Tv ratios of SNPswere found to be 2.51, 2.61,
and 2.52 forWoH,WH, and control samples, respectively, as
shown in Table 3. Ti/Tv ratio for novel variants was also
calculated and it was found to be 1.0 and 1.4 for WoH and
WH, respectively. Accuracy of variant calling was further
validated by calculating dbSNP rate of total variants detected
in each sample. About 95 % of variants detected in all three
samples were already reported in dbSNP database (dbSNP
129) giving an indication of good quality of variant calling.







Smoking Alcohol Tumor site Histopathological examination
WoH Male 45 Indian – – – Right lateral border of
the tongue
Well to moderately differentiated squamous
cell carcinoma
WH Male 47 Indian ? ? ? Left lateral border of the
tongue
Well differentiated keratinizing squamous cell
carcinoma
WH Male 51 Indian ? – – Left lateral border of the
tongue
Well differentiated squamous cell carcinoma
of level grade—I
WH Male 40 Indian ? – – Left tongue Moderately differentiated keratinizing
squamous cell carcinoma
Control Matched normal lymphocytes of WoH and WH
Table 2 Reads mapping details showing number of reads mapped,
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Chromosomal distribution of variants
Chromosome 1, 6, and 17 were found to have highest
number of variants compared to other chromosomes
(Fig. 1a). In order to examine whether this pattern was
coincidental or consistent, the variants that were present in
the exonic regions leading to non-synonymous mutation
were only considered. As can be seen in Fig. 1b, the fre-
quency distribution of exonic non-synonymous variants
was similar to the non-filtered variants across the chro-
mosomes indicating consistency in both findings.
Detection of cancer driver variants and genes
A total of 934 and 959 variants were found in WoH and
WH, respectively, of which 852 and 870 qualified the
confidence criteria (call quality[20). Further, 525 variants
from WoH and 516 from WH, corresponded to exonic
regions, of which 207 and 198, respectively, were non-
synonymous (Fig. 2).
Of the non-synonymous variants 87 were common and
120 and 111 were unique in WoH and WH samples,
respectively (supplementary). In order to classify these
variants into tissue specific (somatic) and germline, vari-
ants from control sample were considered. Out of 87
common variants in both the samples 79 variants were
germline and eight were somatic (Fig. 3). WoH showed 61
germline and 59 somatic variants, whereas WH harbored
72 germline and 39 somatic variants.
These variants were then annotated against dbSNP and
COSMIC databases. 194 variants from WoH and 184 of
WH were found to be already reported in dbSNP database
Fig. 1 Graph showing variant distribution across all chromosomes (a) non-filtered (b) filtered (variants with a call quality[20 and only were in
exonic and non-synonymous)
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(dbSNP 129). Of these, a total of 28 variants were also
reported in COSMIC (Table 4). However, 27 variants could
not be found in either dbSNP or COSMIC and hereafter
referred to as novel. Out of the 27 novel variants, 11 were
predicted to be functionally damaging as depicted from
SIFT and Polyphen2. Therefore, total 39 (28 COSMIC and
11 novel functionally damaging) variants were identified as
causative cancer driver variants in both samples (Table 4).
WoH and WH showed 19 and 20 causative cancer driver
variants, respectively. Comparative assessment revealed
nine common variants in both samples, while 10 and 11
unique variants in WoH and WH, respectively.
Novel variants found in COSMIC involved 17 genes in
case of WoH and 15 in case of WH. A total of 22 unique
genes were found in both WoH and WH subjects. Of
which, 7 (KIT, ATM, RNF213, GATA2, DST, RET, and
CYP2C19) were unique in WoH, 5 (IL7R, PKHD1,
MLL3, PTPRD, and MAPK8) in WH. Genes found to be
common were 10 (SETD2, ATR, CDKN2A, NCOA4,
TP53, SYNE1, KAT6B, THBS1, PTPRT, and FGFR3) in
both samples as shown in Fig. 4. Comparison of candi-
date variants and genes with two of the most compre-
hensive studies in HNSCC, showed no similarity at the
variant level. Further six genes GATA2, IL7R, KAT6B,
MAPK8, NCOA4, and SETD2 were commonly mutated
in all the three datasets i.e., Agrawal, Stranskey, and this
study.
Fig. 2 Analysis workflow
applied parallel to each sample
involving filtering criteria;
variants with a call quality[20
were considered as confidence
variant. These confidence
variants further refined to get
variants occuring only in exonic
and non-synonymous);
functionally damaging
(consequences of variation on
gene and protein function with
the help of bioinformatics)
being considered to identify
candidate causal variants and
genes
Fig. 3 Venn diagram depicting a comparative assessment of non-
synonymous variants from both the samples. Sample 1 (red) and Sample
2 (green). Somatic and germline variants in each sample identified by
comparing with its corresponding matched control. Variants from each
samples found in matched control, were referred as germline whereas
rest (sample specific variants) are considered as somatic. Each sample
depicting non-habitual, habit specific (shown in green), and non-
specific (shown in brown) somatic and germline variants
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Assessment of mutation distribution at gene level
Average percentage mutation rate distribution shared by all
detected cancer panel genes was 0.32 %. While, mutations
shared by cancer driver genes was 0.62 % in all three
samples, which is almost double the average mutations
harbored by all panel genes. PDE4DIP gene emerged as
most mutated gene with a mutation rate of 5.86 % followed
by SYNE1 with a mutation rate (3.07 %) from both the
samples. Other genes exhibiting highest mutation included
PKHD1, LRP1B, NOTCH1, FN1, and RNF213 sharing
1.97, 1.50, 1.33, 1.16, and 1.16 % mutations, respectively,
in both samples.
Discussion
Onset and progression of cancer has been always dynam-
ically linked with various reasons involving physical/or
chemical agents, genetic v/s environment and hence is a
very complex disease. In the present study, an attempt has
been made to understand the genetic difference in the two
different types of HNSCC subjects in the backdrop of habit
(WH) and no habit (WoH). The results obtained showed
distinct pattern with reference to association of genes in
both set of subjects. Number of mutations observed in
subjects with a habit of tobacco was more compared to
number in subjects with no such habit. Association of to-
bacoo, alcohol, and their products in development of var-
ious cancers specially HNSCC is well studied and tobacco
has several carcinogens such as Benzo[a]pyrene diol
epoxide, including benzo[a]pyrene, tobacco-specific
nitrosamines such as nitrosonornicotine, and reactive
aldehydes such as formaldehyde etc. Some of these car-
cinogens like Benzo[a]pyrene diol epoxide is also linked
with induction of genetic damage in the DNA (Denissenko
et al. 1996).
As can be seen from Fig. 1a, b, more number of muta-
tions were distributed on chromosomes 1, 6, and 17.
Chromosome 1 being the largest chromosome with highest
number of genes attributed to highest number of mutations.
Chromosome six harbors the major histocompatibility
complex (Abdulla et al. 1996), and chromosome 17 genes
involved in protein synthesis and gene regulation.
Although the mutations in the chromosomes are generally
considered as random events but there are certain regions
which are more prone to mutation such as repetitive
regions. In case of chromosome 17, percentage of low copy
repeats is more than 23 % and hence is more prone to
mutations (Stankiewicz et al. 2003; Clancy and Shaw
2008). Further, previously reported microsatellite instabil-
ity and loss of heterozygosity during some cancers on
chromosomes 6 and 17 (Roy et al. 2001; Amos et al. 2010;
Lan et al. 2012) support the data obtained. The most
promising variants were found in the q arm of these
chromosomes. Highest mutations occurred in the 1q21
which harbor the PDE4DIP gene, 6q25 harbor the SYNE1
gene, and 17q25 harbor RNF13. Of these PDE4DIP,
SYNE1, and NOTCH1 gene emerged as the genes sharing
highest mutations. This clearly indicates possible role of
PDE4DIP and SYNE1 genes in HNSCC in both the type of
subjects i.e., with or without habits of tobacco; whereas
NOTCH gene family which are mutated only in habitual
subjects suggests its tobacco-dependent role.
Despite a large number of studies on genetic analysis of
HNSCC (Bauman et al. 2012; Agrawal et al. 2011;
Stransky et al. 2011; Poeta et al. 2007), there are no reports
regarding involvement of PDE4DIP in HNSCC. Further,
studies on SYNE1 in case of HNSCC are less characterized
(Stransky et al. 2011) in certain populations. This could be
because most of the studies are from the developed coun-
tries with different races where the genetic makeup, socio-
economic background, food habits are quite different from
those of India. This explanation also holds true for non-
overlap of variants found in this study and those done in the
Western countries.
The protein encoded by PDE4DIP gene serves to
anchor phosphodiesterase 4D to the Golgi/centrosome
region of the cell. The mutations have also been previ-
ously identified as diagnostic marker in esophageal
squamous cell carcinoma (SCC) (Shimada et al. 2007).
SYNE1 gene is known to be involved in nuclear polarity
and spindle orientation (Luke et al. 2008) that function
upstream of NOTCH1 signaling in the squamous cell
differentiation pathway (Williams et al. 2011). Hence,
mutations in both genes may lead to alterations in path-
ways of squamous cell differentiation ultimately leading
to onset of HNSCC.
Table 3 Total number of variants and the corresponding genes, percentage of variants in the dbSNP database and there transition/transversion
ratio for total and novel (not reported in COSMIC and dbSNP) variants
Sample Variants Genes dbSNP (%) Ti/Tv total Ti/Tv novel
Sample 1 (WoH) 934 280 96.90 2.51 1.4
Sample 2 (WH) 959 275 95.50 2.61 1
Sample 3 (control) 1,354 318 94.30 2.52
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Apart from SYNE1 and PKHD1 genes which were
found to be maximally mutated to 22 other genes were
identified as cancer driver genes which harbor 39 variants.
Out of which, 10 genes were common in both the samples
while 7 and 5 genes unique to WoH and WH, respectively.
These genes include NCOA4, SYNE1, SETD2, ATR,
CDKN2A, KAT6B, TP53, FGFR3, THBS1, and PTPRT
common to both the samples whereas CYP2C19, RNF213,
KIT, ATM, GATA2, DST, and RET genes unique to WoH
and IL7R, PKHD1, MLL3, PTPRD, and MAPK8 unique to
WH.
Of the genes commonly found in both the samples,
PTPRT has been previously reported to be frequently
mutated in cancer patients (Zhao et al. 2010). It supposedly
regulates paxillin level which in turn affects regulation of
several signaling pathways. Paxillin also regulates
expression of Nesprin-3 which influences actin diamines.
Since any disturbance in the regulation of actin dynamics
may lead to the disformation of the core cytoskeleton
PTPRT may be having a role in the disfigurement during
HNSCC. Further, CDKN2A, ATR, THBS1, NCOA4,
PTPRD, TP53, and ATM are known tumor suppressor
genes (McLendon et al. 2008; Pardali and Moustakas 2007;
Painter and Young 1980; Ligr et al. 2010; Bose et al. 2009;
Kohno et al. 2010). Alteration of tumor-suppressor genes
may allow cellular proliferation to continue with unregu-
lated and autonomous, self-sufficient growth (Field et al.
1993) thereby initiating cancerous growth. Mutations in
TP53 are shown to exist in over 50 % of HNSCC lesions
(Argiris et al. 2008) and have been shown to be one of the
most common genetic abnormalities in human cancers
(Field et al. 1993). NCOA4 expression studies have
reported its role in oral cancer and recognized as candidate
serum markers for oral squamous cell carcinomas (OSCC)
(Kollara and Brown 2012). CDKN2A binds to CDK4 and
CDK6 and suppresses proliferation by inhibiting cells
progressing from G1 into S phase (Liggett and Sidransky
1998), and has also been recognized as an early event in the
progression of pre-malignant lesions leading to HNSCC
(Schwarz et al. 2008). PTPRD is previously reported can-
didate tumor suppressor gene in lung cancer (Kohno et al.
2010).
Among the unique genes associated with WoH,
mutation in GATA2 has been reported to be involved in
dysplasia (Fadilah et al. 2002). Similarly, DST gene is a
protein coding gene required for anchoring either inter-
mediate filaments to the actin cytoskeleton in neural and
muscle cells (Dalpe et al. 1998) or keratin-containing
intermediate filaments to hemidesmosomes in epithelial
cells. Since HNSCC involves transformation of squamous
epithelial lineage, presence of mutation in genes dis-
rupting epithelia leading to development of cancer is
justified. DNA damage sensor and control genes (ATM
and ATR), (Goldgar et al. 2011; Tanaka et al. 2012)
were also found to harbor mutation thereby disrupting
the DNA damage control pathway. RNF213 gene is
involved in the pathogenesis of moyamoya disease which
has been reported to be both congenital and acquired
(Sonobe et al. 2014; Mineharu et al. 2013). Actual role
of this gene in HNSCC is not known but it may have a
probable role in angiogenesis reported in advanced stages
of cancer.
One very interesting mutation was found in the RET
gene which suggests a genetic basis for development of
HNSCC in WoH subjects. Mutations in RET gene are
reportedly germline and has function of signaling pathway
of tyrosine kinase. Further, it is also reported that specific
mutations in this gene leads to development of specific
tumors. For example, single point mutation at codon 918
results in Multiple Endocrine Neoplasia (Mulligan et al.
1995) and that in codon 664 lead to small cell lung carci-
noma (Futami et al. 1994). In this study, we report a novel
germline mutation of codon 831 which converts glycine to
valine (Table 4). Functionally this mutation affects the
tyrosine kinase domain of the protein thereby probably
disturbing the substrate specificity. Further validation of
the mutations in this gene with more subjects may provide
substance to suggest a genetic basis in occurrence of
HNSCC in WoH subjects.
Another important gene uniquely mutated in WoH was
CYP2C19 gene. This gene is responsible for xenobiotic
metabolism (Marzo and Balant 1996). It is also involved in
the activation of different carcinogen and/or inactivation of
cancer-related drugs (Antona and Sundberg 2006). Thus it
may be suggested that mutations in this gene may have role
in the effect of drug during therapy of HNSCC. Thus
mutations in this gene may be assessed before starting a
cancer treatment for effective drug effect.
Fig. 4 Venn diagram showing cancer driver genes in each sample.
Genes in red and green background are unique to non-habitual and
habitual sample, respectively; genes in gray background common to
both the samples
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On the other hand, the unique mutated genes in WH
subjects i.e., sample 2 included IL7R, PKHD1, MLL3,
PTPRD, and MAPK8. IL7R is reported in childhood T-cell
acute lymphoblastic leukemia, promotes cell transforma-
tion and tumor formation (Zenatti et al. 2011). Of these,
MLL3 is a known tumor suppressor gene (Lee et al. 2009)
which contributes to chromatin remodeling and transcrip-
tional regulation in cancers (Fujimoto et al. 2012; Zang
et al. 2012). It also has a key role in PI3K pathway
(intracellular signaling pathway important in apoptosis),
activation of which is a hallmark of a variety of malig-
nancies, including melanoma and high-grade astrocytomas
(McLendon et al. 2008; Lui et al. 2013). Additionally both
IL7R and MLL3 reportedly affect histone acetyl binding
(Chowdhury and Sen 2003; Li et al. 2013). Histone acet-
ylation and deacytylation is not only important for regu-
lation of genes involved in the genesis of cancer but also
regulation of angiogenesis that permits increased tumor
growth as well as the regulation of adhesion, cell migra-
tion, and invasion required for metastasis. Further, PTPRD
is a known tumor suppressor for lung cancer (Kohno et al.
2010); glioblastoma (Veeriaha et al. 2009). It is a central
feature in signaling cascades such as signal transducers and
activators of transcription (STAT3) pathway (Veeriaha
et al. 2009) involved in oncogenesis (Lui et al. 2013).
Further, MAPK8 gene is known to be stimulated by
tobacco smoke thereby disturbing the MAPK pathway, an
important targetable pathway in HNSCC (Lui et al. 2013).
PKHD1 induces cell apoptosis through PI3K and NF-jB
pathways (Sun et al. 2011).
Thus analysis of the exclusive gene mutations in the
WoH subject indicates that it is the mutation in epithelial
transformation and DNA damage repair genes which in
turn lead to HNSCC. In view of the RNF13 gene, the study
also suggests genetic origin of HNSCC. In contrast to this
in case of WH subjects most of the mutations are directly in
the oncogeneic genes probably because tobacco itself is
carcinogenic and no hereditary basis was found.
Conclusion
Thus one can suggest that in case of non-tobacco chewers,
mutation in the genes involved in squamous epithelial
development and DNA repair genes lead to HNSCC, while
it is the carcinogen tobacco in chewers which leads to the
stimulation of various oncogenes and tumor suppressor
genes leading to HNSCC. Further, presence of novel
mutations not reported earlier in HNSCC patients also
suggest that Indian sub-continent may have different sets of
genes, as compared to other parts of the world, involved in
the development and progression of HNSCC. However, we
need to strengthen the statements by further sequencing of
the subset of the shortlisted genes from each sample on a
larger sample patient’s population.
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